Orlando, FL -- (SBWIRE) -- 07/24/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On: Arch Therapeutics Inc (OTCBB:ARTH), Delcath Systems, Inc. (NASDAQ:DCTH).
Arch Therapeutics Inc(OTCBB:ARTH), has said that its co-founder and inventor, Dr. Rutledge Ellis-Behnke, delivered a lecture titled "The Spider Effect, how the Immune System in the Brain can be Measured and Modulated with Nanotechnology" at the 6th annual European Foundation for Clinical Nanomedicine (CLINAM) Summit in Basel, Switzerland.
Where is ARTH headed, before you make another move get a free trend analysis on ARTH HERE
He spoke on the groundbreaking system he designed to categorize the activation status of microglia using morphological attributes.
Ellis-Behnke said: "Inflammation is often only treated for two weeks. However, our work indicates that inflammation can last far longer than that before returning to a resting state, suggesting that inflammation needs to be treated far longer than was once thought. In order to modulate these responses, it is important to control the leakage of blood within and between tissue components as well as in the local environment. This can be accomplished with novel materials."
Arch Therapeutics Chief Executive, Dr. Terrence Norchi spoke of Ellis-Behnke: "Dr. Ellis-Behnke is at the forefront of emerging trends in nanomedicine and the advice he provides our Company continues to be of great importance. He is the lead inventor on the intellectual property exclusively licensed by Arch Therapeutics from the Massachusetts Institute of Technology and his work offers strategic insights that shape our future and the roadmap for our success."
Meanwhile, Delcath Systems, Inc.(NASDAQ:DCTH) has announced that it will discuss its financial results for the second quarter ended June 30, 2013 on a conference call and webcast on Tuesday, August 6, 2013 at 4:30 p.m. ET. It will also provide a coroporate update.
Is DCTH going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
The numbers for the conference call are 866-804-6922 (U.S. participants) and 857-350-1668 (international participants). The passcode for both is 85959025. For the live webcast, viewers will have to go to the Events & Presentations page in the Investor Relations section of our website-http://www.delcath.com/investors/events/.
A taped replay will be available for seven days. The phone numbers for the replay are 888-286-8010 (US) and 617-801-6888 (International). The passcode for both is 21059318. The archived webcast will also be available at http://www.delcath.com/investors/events/.
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)